Mirum Pharmaceuticals, Inc.
- MIRM
- NASDAQ
- Biotechnology
- Rare Disease Therapeutics
- Orphan Drugs
- Hepatology (PFIC)
$81.11
Today +1.21%Quote Oct 19, 2026, 02:34 PM UTC
−18.90%over the last month
Max drawdown −19.8%From 1-month high −18.9%3 months −31.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$5.27B
Quote Oct 19
Next earnings
Nov 3
Expected, not confirmed
Analyst target
$153.20
+88.9% from here
Floor
$79.93
1.5% below price
Where the price sits
18 analysts
Analyst range, low to high
$130.00$200.00
- Price $81.11
- Resistance $83.86
- Consensus $153.20
The price is just above its floor. Analysts' average target sits about 89% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MIRMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
433
Founded
2018